Dr. Axel Dehn
Head of Pharmacovigilance (QPPV)
Dr. Dehn joined Biopartners in 2007 as Stufenplanbeauftragter (Germany) and Deputy QP-PV. In 2009 he took over the position as Head of Pharmacovigilance. He is the responsible person for pharmacovigilance issues in Europe and World Wide. Prior to this he held various senior positions with preclinical, clincal and pharmacovigilance responsibilities in multinational companies like Schwarz Pharma AG and Solvay Pharmaceuticals GmbH where he gained substantial experience. Dr. Dehn holds a PhD from the Medical School in Hannover and a Masters degree from Tulane University, New Orleans, USA.
